Lexaria Bioscience Corp expected to post a loss of 12 cents a share - Earnings Preview

Lexaria Bioscience

08/01/2025 21:03

* Lexaria Bioscience Corp  LEXX.OQ   LEXX.O  is expected
to report
resultson January 10 (estimated) for the period ending November
30 2024
    * The Kelowna British Columbia-based  company is expected to
report revenue of $100 thousand, according to the estimate from
one analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Lexaria Bioscience Corp
is for
a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lexaria
Bioscience Corp is $10.00​, above​ its last closing price
of $2.24. ​​​

This summary was machine generated January 8 at 21:02 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)